Recombinant Human LAIR1 protein, His-Avi-tagged, Biotinylated

• Cat.No.: LAIR1-523H
• Product Overview: Biotinylated Recombinant Human LAIR1 protein(Gln 22 - His 163), fused with His and Avi tag, was expressed in HEK293.

Specification

• Source: HEK293
• Species: Human
• Tag: His-Avi
• Form: Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
• Molecular Mass: This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™).The protein has a calculated MW of 19.2 kDa. The protein migrates as 30-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
• Proteinlength: Gln22-His163
• Endotoxin: Less than 1.0 EU per μg by the LAL method.
• Purity: >95% as determined by SDS-PAGE.
• Storage: For long term, the product should be stored at lyophilized state at -20°C or lower.Please avoid repeated freeze-thaw cycles. This product is stable after at:
  -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.

Gene Information

• Gene Name: LAIR1 leukocyte-associated immunoglobulin-like receptor 1 [ Homo sapiens ]
• Official Symbol: LAIR1
• Synonyms: LAIR1; leukocyte-associated immunoglobulin-like receptor 1; leukocyte associated Ig like receptor 1; CD305; hLAIR1; leukocyte-associated Ig-like receptor 1; LAIR-1
• Gene ID: 3903
• mRNA Refseq: NM_002287
• Protein Refseq: NP_002278
• MIM: 602992
• UniProt ID: Q6GTX8

Reviews

09/06/2021

Another advantage of using LAIR1 protein in trials is its potential as a therapeutic agent.

01/03/2020

The manufacturer's support and expertise further enhance the utility of LAIR1 in my experimental work, ensuring reliable and high-quality results.

01/27/2017

This collaborative partnership greatly contributes to the success of my research projects and facilitates meaningful contributions to the scientific community.

Q&As

How can LAIR1 impact the field of regenerative medicine?

LAIR1's role in immune regulation may have implications for reducing immune rejection in regenerative medicine and tissue engineering.

Are there any ongoing clinical trials involving LAIR1 protein?

Some clinical trials are exploring the therapeutic potential of targeting LAIR1 in cancer immunotherapy and autoimmune disease management.

How can LAIR1 protein impact immunotherapy approaches?

LAIR1 can be targeted to enhance the effectiveness of immunotherapy, as inhibiting LAIR1 may boost the immune system's response against cancer cells.

Is LAIR1 protein involved in inflammatory conditions?

Yes, LAIR1's role in immune modulation makes it relevant in inflammatory conditions. Targeting LAIR1 may be a strategy to manage inflammation.

Are there any drugs or biologics targeting LAIR1 in development?

There are experimental drugs and biologics that target LAIR1 currently in preclinical and early clinical development.